Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | CHIEF TECHNICAL OPS OFFICER | July 09, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,299 |
Ending reported balance
After 2026-07-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-09 · Exercise / conversion · Acquired 2,464 · Balance 62,763 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Row 2 · 2026-07-09 · Sale · Disposed 2,464 · Balance 60,299 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.54 · Expires 2035-01-02 | Direct | 45,036 |
Reported balance
After 2026-07-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-09 · Exercise / conversion · Disposed 2,464 · Balance 45,036 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. F3: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 2,899 |
Reported balance
Holding disclosure · report date 2026-07-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,899 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.
F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 5,715 | $11.23 | $64,179.45 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 13 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 4,188 | $60.59 | $253,742.54 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 12 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F8 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.39 to $61.24 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 4,188 | $18.01 | $75,425.88 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 11 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,188 | $60.54 | $132,465.90 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 10 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.42 to $60.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,188 | $11.23 | $24,571.24 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 9 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 100 | $61.36 | $6,136.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 8 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,935 | $60.56 | $177,740.67 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 7 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,189 F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.22 to $60.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 3,035 | $11.23 | $34,083.05 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 6 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 10, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 200 | $61.25 | $12,249.00 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $61.24 to $61.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 32,571 | $60.58 | $1,973,020.90 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,289 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.18 to $61.12 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 32,771 | $27.05 | $886,455.55 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 7,229 | $60.59 | $438,012.34 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.40 to $61.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 7,229 | $27.05 | $195,544.45 |
DisclosureSEC source: 0001179110-21-000315 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,875 | $11.23 Strike: $11.23 | $245,656.25 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · derivative · entry 6 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 21,875 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 2,187 | $11.23 Strike: $11.23 | $24,560.01 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · derivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,813 Underlying: Common Stock · 2,187 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 21,875 | $60.00 | $1,312,500.00 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 21,875 | $11.23 | $245,656.25 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,187 | $60.00 | $131,220.00 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:27 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,187 | $11.23 | $24,560.01 |
DisclosureSEC source: 0001179110-20-010865 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the Reporting Person on August 16, 2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 3,102 | $10.85 Strike: $10.85 | $33,656.70 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · derivative · entry 8 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,102 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 46,898 | $10.85 Strike: $10.85 | $508,843.30 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · derivative · entry 7 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,898 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 4,040 | $55.00 | $222,200.00 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 6 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,912 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 3,102 | $55.00 | $170,610.00 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 3,102 | $10.85 | $33,656.70 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 46,898 | $55.00 | $2,579,390.00 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 46,898 | $10.85 | $508,843.30 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:41 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 405 | $55.00 | $22,275.00 |
DisclosureSEC source: 0001070081-20-000057 · wf-form4_158111165404736.xml · nonDerivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,952 F1 · kind: The transactions reported in this Form 4 were effected pursuant to written Rule 10b5-1 plans. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right To Buy) · Derivative | 69,500 | $0.00 Strike: $51.16 | $0.00 |
DisclosureSEC source: 0001070081-20-000047 · wf-form4_158050681627427.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,500 Underlying: Common Stock · 69,500 shares Expires 2030-01-28 F2 · derivative.exercise_date: This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 370 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-20-000047 · wf-form4_158050681627427.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,357 F1 · shares: Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 21:40 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-20-000047 · wf-form4_158050681627427.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · shares: Restricted stock units granted on January 29, 2020 that vest in four equal installments over four years, commencing on January 29, 2021. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 21:09 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 46 | $53.25 | $2,449.36 |
DisclosureSEC source: 0001070081-20-000022 · wf-form4_158015935890747.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,987 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 142 RSUs from a January 22, 2019 grant of 570 RSUs. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 23:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 59 | $49.62 | $2,927.64 |
DisclosureSEC source: 0001070081-20-000012 · wf-form4_157852477577567.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,033 F4 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 188 RSUs from a January 4, 2016 grant of 750 RSUs. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 23:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 57 | $48.17 | $2,745.58 |
DisclosureSEC source: 0001070081-20-000012 · wf-form4_157852477577567.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,092 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 23:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 70 | $48.17 | $3,371.76 |
DisclosureSEC source: 0001070081-20-000012 · wf-form4_157852477577567.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,149 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 219 RSUs from a January 3, 2018 grant of 874 RSUs Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 23:06 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 507 | $48.17 | $24,421.18 |
DisclosureSEC source: 0001070081-20-000012 · wf-form4_157852477577567.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,889 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2029-01-21 F3 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 72,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · derivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,500 Underlying: Common Stock · 72,500 shares Expires 2029-01-21 F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 22:45 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 570 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-003197 · a4.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,219 F1 · shares: Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 68 | $34.75 | $2,363.00 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,649 F6 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 218 RSUs from a January 3, 2018 grant of 874 RSUs. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 55 | $34.75 | $1,911.25 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,717 F5 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 57 | $34.75 | $1,980.75 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,772 F3 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 187 RSUs from a January 4, 2016 grant of 750 RSUs. F4 · balance_after: Includes 704 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 473 | $34.75 | $16,436.75 |
DisclosureSEC source: 0001070081-19-000012 · wf-form4_154707207004473.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · Chief Technical Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,396 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock. F2 · balance_after: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 20,000 | $10.85 Strike: $10.85 | $217,000.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · derivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,898 Underlying: Common Stock · 20,000 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F4 · derivative.exercise_date: Currently exercisable. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 12,000 | $48.46 | $581,520.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $48.38 to $48.81 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 8,000 | $48.09 | $384,720.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.58 to $48.37 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 20,000 | $10.85 | $217,000.00 |
DisclosureSEC source: 0001070081-18-000056 · wf-form4_152961316540176.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 82 | $18.03 | $1,478.46 |
DisclosureSEC source: 0001070081-18-000031 · wf-form4_151553878007729.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,125 F3 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 188 RSUs from a January 4, 2016 grant of 750 shares. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 621 | $18.03 | $11,196.63 |
DisclosureSEC source: 0001070081-18-000031 · wf-form4_151553878007729.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares. F2 · balance_after: Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 21:09 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 77 | $17.67 | $1,360.59 |
DisclosureSEC source: 0001070081-18-000018 · wf-form4_151518652790156.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,207 F3 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 shares. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right To Buy) · Derivative | 70,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000018 · wf-form4_151518652790156.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-01-02 F4 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.